Recalls / Active ingredient / Esomeprazole Magnesium
Esomeprazole Magnesium
6 FDA drug recalls involving the active ingredient “Esomeprazole Magnesium”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2023-10-23 | Class III | Esomeprazole Magnesium Delayed-Release Capsules, USP 20mg, Packaged as (a) 30-count bottle, NDC 68462-390-30; | Glenmark Pharmaceuticals Inc., USA |
| 2022-06-21 | Class III | Esomeprazole Magnesium Delayed-Release Capsules, USP, 40mg, Rx Only, 90 Capsules per bottle, Manufactured by: | SUN PHARMACEUTICAL INDUSTRIES INC |
| 2022-06-21 | Class III | Esomeprazole Magnesium Delayed-Release Capsules, USP 20mg, Rx Only, 90 Capsules per bottle, Manufactured by: O | SUN PHARMACEUTICAL INDUSTRIES INC |
| 2020-12-17 | Class II | Esomeprazole Magnesium for Delayed-Release Oral Suspension 10mg, packaged in unit dose packets, Rx only, Manuf | CIPLA |
| 2020-04-24 | Class III | Esomeprazole Magnesium Delayed Release Capsules USP, 40 mg*, 1000-count bottles, Rx only, Mfd. By: Dr. Reddy' | Dr. Reddy's Laboratories, Inc. |
| 2019-02-06 | Class III | Esomeprazole Magnesium Delayed-Release Capsules USP, 40mg*, a) 90-count bottle (NDC 43598-510-90) b) 1000 coun | Dr. Reddy's Laboratories, Inc. |